Penumbra Inc - Asset Resilience Ratio
Penumbra Inc (PEN) has an Asset Resilience Ratio of 22.97% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Penumbra Inc (PEN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Penumbra Inc balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Penumbra Inc to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $453.52 Million | 22.97% |
| Total Liquid Assets | $453.52 Million | 22.97% |
Asset Resilience Insights
- Good Liquidity Position: Penumbra Inc maintains a healthy 22.97% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Penumbra Inc Industry Peers by Asset Resilience Ratio
Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Penumbra Inc (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 29.83% | $544.82 Million | $1.83 Billion | +7.64pp |
| 2024-12-31 | 22.18% | $340.13 Million | $1.53 Billion | +3.60pp |
| 2023-12-31 | 18.58% | $289.19 Million | $1.56 Billion | +4.87pp |
| 2022-12-31 | 13.72% | $188.03 Million | $1.37 Billion | -6.77pp |
| 2021-12-31 | 20.48% | $254.88 Million | $1.24 Billion | -11.70pp |
| 2020-12-31 | 32.18% | $264.83 Million | $822.98 Million | +3.74pp |
| 2019-12-31 | 28.44% | $189.39 Million | $665.90 Million | -10.57pp |
| 2018-12-31 | 39.01% | $200.89 Million | $515.01 Million | -6.01pp |
| 2017-12-31 | 45.02% | $214.59 Million | $476.67 Million | +3.25pp |
| 2016-12-31 | 41.77% | $128.75 Million | $308.25 Million | -7.22pp |
| 2015-12-31 | 48.99% | $129.26 Million | $263.85 Million | +9.24pp |
| 2014-12-31 | 39.75% | $48.25 Million | $121.38 Million | +26.34pp |
| 2013-12-31 | 13.42% | $9.54 Million | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more